个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共53条记录   Two Cases with a Long-term Survival Following Multidisciplinary Treatment for Recurrent Breast Cancer After Surgery [作者：Uramoto, H; Hanagiri, T,期刊：Anticancer Research, 页码：277-279 , 文章类型： Article，,卷期：2011年31-1] Recurrent breast cancer (BC) tends to show an aggressive behavior and the number of cases of long-term survival is limited. Two rare cases of recurrent breast cancer were treated with a multidisciplinary approach. The ou... C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib [作者：Cstoth, I; Anthoine, G; Berghmans, T; Mascaux, C; Paesmans, M; Sculier, JP; Meert, AP,期刊：Anticancer Research, 页码：281-285 , 文章类型： Article，,卷期：2011年31-1] Background: The clinical impact of c-erbB-3 has seldom been assessed in patients with non small cell lung cancer (NSCLC). Patients and Methods: Forty-three NSCLC patients treated by erlotinib for c-erbB-3 and EGFR expres... A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer [作者：Takeyoshi, I; Makita, F; Tanahashi, Y; Iwazaki, S; Ogawa, T; Tomizawa, N; Nakamura, S; Ishikawa, H; Ohya, T; Kakinuma, S; Nakagami, K; Sato, Y; Koyano, T; Roppongi, T; Izumi, M; Kobayashi, J; Kawate, S; Sunose, Y; Kobayashi, M; Yamada, T; Sakamoto, I,期刊：Anticancer Research, 页码：287-291 , 文章类型： Article，,卷期：2011年31-1] Background: Paclitaxel and doxifluridine (5'-DFUR) have distinct mechanisms of action and toxicity profiles. This study evaluated the antitumor activity and toxicities of combination chemotherapy with these drugs in pati... Cortactin in Breast Cancer: Analysis with Tissue Microarray [作者：Sheen-Chen, SM; Huang, CY; Liu, YY; Huang, CC; Tang, RP,期刊：Anticancer Research, 页码：293-297 , 文章类型： Article，,卷期：2011年31-1] Background: Tissue microarray (TMA) allows the rapid immunohistochemical analysis of thousands of tissue samples in a parallel fashion. This study was designed to analyze the cortactin status in breast cancer using TMA a... Successful S-1 Monotherapy for Chemorefractory Thymic Carcinoma [作者：Koizumi, T; Agatsuma, T; Komatsu, Y; Kubo, K,期刊：Anticancer Research, 页码：299-301 , 文章类型： Article，,卷期：2011年31-1] The optimal chemotherapeutic regimen for inoperable thymic carcinoma remains uncertain and little information is available regarding the usefulness of salvage chemotherapy. S-1, a newly developed oral fluorouracil antitu... Prognostic Value of the Human Antigen R (HuR) in Human Breast Cancer: High Level Predicts a Favourable Prognosis [作者：Yuan, Z; Sanders, AJ; Ye, L; Wang, Y; Jiang, WG,期刊：Anticancer Research, 页码：303-310 , 文章类型： Article，,卷期：2011年31-1] Background: The role of human antigen R (HuR) and its prognostic value in breast cancer is currently only partially understood. This study aimed to determine the levels of expression of HuR in breast cancer and assess it... Pronounced Tumour Regression after Radiotherapy is Associated with Negative/Weak Glucose Transporter-1 Expression in Rectal Cancer [作者：Korkeila, E; Jaakkola, PM; Syrjanen, K; Pyrhonen, S; Sundstrom, J,期刊：Anticancer Research, 页码：311-315 , 文章类型： Article，,卷期：2011年31-1] The aim of this study was to assess glucose transporter-1 (GLUT-1) expression as a predictor of disease outcome in rectal cancer treated by preoperative radio- or chemoradiotherapy. Patients and Methods: Operative sample... Randomized Phase II Study of Paclitaxel and Carboplatin or Vinorelbine in Advanced Non-small Cell Lung Cancer [作者：Jahnke, K; Keilholz, U; Luftner, D; Thiel, E; Schmittel, A,期刊：Anticancer Research, 页码：317-323 , 文章类型： Article，,卷期：2011年31-1] Background: A randomized phase II trial was conducted to detertnine if two non-platinum protocols are able to yield a similar efficacy and toxicity profile as compared to two platinum-based doublets in advanced non-small... Clinical Significance of STC1 Gene Expression in Patients with Colorectal Cancer [作者：Tamura, S; Oshima, T; Yoshihara, K; Kanazawa, A; Yamada, T; Inagaki, D; Sato, T; Yamamoto, N; Shiozawa, M; Morinaga, S; Akaike, M; Kunisaki, C; Tanaka, K; Masuda, M; Imada, T,期刊：Anticancer Research, 页码：325-329 , 文章类型： Article，,卷期：2011年31-1] Background: Recent studies suggest that altered patterns of stanniocalcin 1 (STC1) gene expression have a role in human carcinogenesis. This study examined the relationship between the relative expression of the STC1 gen... Temsirolimus in Metastatic Chromophobe Renal Cell Carcinoma after Interferon and Sorafenib Therapy [作者：Paule, B; Brion, N,期刊：Anticancer Research, 页码：331-333 , 文章类型： Article，,卷期：2011年31-1] Chromophobe renal cell carcinoma (chRCC) is a common subtype of renal cell carcinoma (RCC), occurring in 6-11% of renal carcinoma patients. Limited clinical trial data have shown minimal activity with cytokines and chemo... Inhibition of Tumor Cellular Proteasome Activity by Triptolide Extracted from the Chinese Medicinal Plant 'Thunder God Vine' [作者：Lu, L; Kanwar, J; Schmitt, S; Cui, QC; Zhang, CY; Zhao, C; Dou, QP,期刊：Anticancer Research, 页码：1-10 , 文章类型： Article，,卷期：2011年31-1] Aims: The molecular mechanisms of triptolide responsible for its antitumor properties are not yet fully understood. The ubiquitin/proteasome system is an important pathway of protein degradation in cells. This study inve... Frequent Absence of Tumor Suppressor FUS1 Protein Expression in Human Bone and Soft Tissue Sarcomas [作者：Li, GD; Kawashima, H; Ji, L; Ogose, A; Ariizumi, T; Umezu, H; Xu, YJ; Hotta, T; Endo, N,期刊：Anticancer Research, 页码：11-21 , 文章类型： Article，,卷期：2011年31-1] Background: FUS1 is a tumor suppressor gene located on human chromosome 3p21.3. Frequent loss of FUS1 protein expression is associated with lung cancer development. This study examined FUS1 expression and its possible tu... 5-FU-induced Hyperammonemic Encephalopathy in a Case of Metastatic Rectal Adenocarcinoid Successfully Rechallenged with the Fluoropyrimidine Analog, Capecitabine [作者：Advani, PP; Fakih, MG,期刊：Anticancer Research, 页码：335-338 , 文章类型： Article，,卷期：2011年31-1] Neurological complications of both fluorouracil (5-FU) and its oral prodrug, capecitabine, have been described in the literature. This study reported the case of a 70-year-old female with metastatic adenocarcinoid of the... Predictive Value of Serum Biomarkers in Patients After Portal Vein Embolization (PVE): A Pilot Study [作者：Treska, V; Topolcan, O; Vrzalova, J; Skalicky, T; Sutnar, A; Liska, V; Fichtl, J; Narsanska, A; Ferda, J; Treskova, I; Mirka, H; Kreuzberg, B,期刊：Anticancer Research, 页码：339-344 , 文章类型： Article，,卷期：2011年31-1] Background/Aim: Insufficient growth of the liver or tumor progression is an important issue of portal vein embolization (PVE) in some patients. This study evaluated the predictive value of serum biomarkers for liver hype... The Dynamics of Serum Tumor Markers in Predicting Metastatic Uveal Melanoma (Part 1) [作者：Barak, V; Kaiserman, I; Frenkel, S; Hendler, K; Kalickman, I; Pe'er, J,期刊：Anticancer Research, 页码：345-349 , 文章类型： Article，,卷期：2011年31-1] Aim: To examine the kinetics of the tumor marker levels: osteopontin (OPN), S-100 beta, melanoma inhibitory activity (MIA) and tissue polypeptide-specific antigen (TPS), and to evaluate their potential for predicting ear... Measuring IGF-1, ER-alpha and EGFR Expression Can Predict Tamoxifen-resistance in ER-positive Breast Cancer [作者：Chong, K; Subramanian, A; Sharma, A; Mokbel, K,期刊：Anticancer Research, 页码：23-32 , 文章类型： Article，,卷期：2011年31-1] In vitro studies have suggested that tamoxifen resistance may be due to altered expression and downstream signalling of insulin-like growth factor-1 (IGF-1) receptor (IGF-1l), oestrogen receptor-alpha (ER alpha), epiderm...